Announcements
- Addex to Present at the Swiss Biotech Day 2024
- Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
- Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
- Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
- Addex to Present at the Bio-Europe Spring 2024 Conference
- Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
- Addex to Present at the Swiss Equities Baader Conference
- Addex to Present at Biotech Showcase™ 2024
- Addex Shareholders Approve All Resolutions at Extraordinary General Meeting
- Addex Creates Treasury Shares
More ▼
Key statistics
On Tuesday, Addex Therapeutics Ltd (APE:BRN) closed at 0.138, -21.59% below its 52-week high of 0.176, set on May 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.143 |
---|---|
High | 0.143 |
Low | 0.138 |
Bid | -- |
Offer | -- |
Previous close | 0.147 |
Average volume | 3.75k |
---|---|
Shares outstanding | 184.35m |
Free float | 153.41m |
P/E (TTM) | -- |
Market cap | 21.29m CHF |
EPS (TTM) | -0.1433 CHF |
Data delayed at least 15 minutes, as of Apr 23 2024.
More ▼